Anticipating and strategizing to address potential bottlenecks during clinical research projects in sub-Saharan Africa: a case for adapting approaches and tools used in the entrepreneurial and development sectors

Yauba Saidu,Sangwe Clovis Nchinjoh,Amani Adidja,Andreas Frambo Besong,Palmer Masumbe Netongo,Paul Ndom,Marya Liebermann
DOI: https://doi.org/10.1186/s13063-023-07897-7
IF: 2.728
2024-02-06
Trials
Abstract:Many research funders have invested billions of US dollars in building research capacity in sub-Saharan Africa (SSA). Despite these colossal investments, many well-intentioned and designed clinical research projects have either failed to kick off or ended abruptly. Although obstacles to clinical research in SSA are well known, there is limited information on frameworks and tools that can be used to anticipate and avert these systemic bottlenecks, particularly those related to socio-politics. In this paper, we leveraged lessons from entrepreneurs and development experts in harsh and uncertain business environments to develop a framework for anticipating and addressing potential bottlenecks to clinical research in SSA. More so, to illustrate and build a case for this framework, we shared our experience in supporting clinicians and regulators to adopt a point-of-use care tool, the "chemoPAD," to screen for the quality of anticancer medications rapidly and systematically in Cameroon despite resistance from some stakeholders. The critical steps in this framework involve identifying stakeholders, categorizing them based on their potential reactions to the study (adversary, supporters, and indifferents), and developing critical strategies to engage or deal with each stakeholder's reactions, starting with adversaries. This approach may be useful in complex research projects, especially clinical trials, which often involve many stakeholders with different interests and perceptions.
medicine, research & experimental
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the potential bottlenecks faced when conducting clinical research projects in sub - Saharan Africa. Although many research funders have invested billions of dollars in this region to build research capacity, many well - designed clinical research projects either fail to start or are suddenly terminated. The failure of these projects not only wastes resources but also affects the public health development in this region. The paper points out that although the obstacles hindering clinical research are well - known, the existing frameworks and tools are very limited in terms of how to foresee and avoid these systemic bottlenecks, especially those related to sociopolitical issues. To meet this challenge, the author draws on the experiences of entrepreneurs and development experts in harsh and uncertain business environments to develop a framework for foreseeing and resolving potential bottlenecks in clinical research in sub - Saharan Africa. This framework identifies stakeholders, classifies them according to their possible reactions to the research (opponents, supporters, neutrals), and formulates strategies to deal with the reactions of each stakeholder, especially starting with opponents. This approach is particularly useful for complex clinical trials because such trials usually involve multiple stakeholders with different interests and views.